Recent advances and clinical translation of liposomal delivery systems in cancer therapy

Area of Science:

• Oncology
• Nanomedicine
• Drug Delivery Systems

Background:

• Conventional cancer treatments face limitations, driving innovation in nanomedicine.
• Liposomal nanomedicine shows promise for targeted cancer therapy, enhancing efficacy and minimizing damage to healthy tissues.
• Research in liposomal nanomedicine for cancer treatment is rapidly expanding.

Purpose of the Study:

• To elucidate the advantages of liposomal delivery systems in cancer therapy.
• To review the spatiotemporal fate of liposomes following various administration routes.
• To discuss diverse liposome-based systems and their therapeutic benefits and side effect profiles.

Main Methods:

• Literature review of recent advancements in liposomal nanomedicine for cancer.
• Analysis of studies detailing liposome biodistribution and targeting mechanisms.
• Examination of combination therapies involving liposomal agents.

Main Results:

• Liposomal systems offer improved therapeutic effects and reduced toxicity in cancer treatment.
• Understanding liposome fate in vivo aids in optimizing drug delivery strategies.
• Combination therapies, including photodynamic and photothermal therapy, enhance tumor targeting and efficacy.
• Various liposome formulations present distinct advantages for specific cancer applications.

Conclusions:

• Liposomal nanomedicine presents significant advantages for cancer therapy, including targeted delivery and reduced side effects.
• Further research into liposome formulations and combination strategies can improve clinical outcomes.
• Addressing challenges in liposome nanoformulations is crucial for their successful translation into clinical practice.